Track: CME Session

SESSION 9: PROGRESS IN THE TREATMENT OF VARIANT HISTOLOGY RCC

Moderator(s)

• 

  Cristina Suárez Rodríguez, Sr., MD, PhD (she/her/hers)

  Attending Physician
  Vall d'Hebron University Hospital
  Barcelona, Catalonia, Spain
• 

  Michael Atkins, MD (he/him/his)

  Vice Chair of Department of Medical Oncology
  Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  Georgetown-Lombardi Comprehensive Cancer Center
  WAshington, District of Columbia, United States

Presentations:

• 11:11 – 11:12 GMT

  Introduction to Session 9
  

  Moderator: Cristina Suárez Rodríguez, Sr., MD, PhD (she/her/hers) – Vall d'Hebron University Hospital
• 11:12 – 11:24 GMT

  Papillary RCC
  

  Speaker: Manuela Schmidinger, MD – Medical University of Vienna, Austria
• 11:24 – 11:36 GMT

  Chromophobe RCC
  

  Speaker: Stéphane Oudard, PhD, MD (he/him/his) – Georges Pompidou Hospital
• 11:36 – 11:48 GMT

  Collecting Duct and Renal Medullary Carcinoma
  

  Speaker: Giuseppe Procopio, MD – Fondazione IRCCS Istituto Nazionale Tumori
• 11:49 – 12:00 GMT

  HLRCC and Translocation RCC
  

  Speaker: Nizar M. Tannir, MD FACP (he/him/his) – University of Texas MD Anderson Cancer Center
• 12:00 – 12:10 GMT

  Session 9 Q&A
  

  Moderator: Cristina Suárez Rodríguez, Sr., MD, PhD (she/her/hers) – Vall d'Hebron University Hospital

  Moderator: Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.